Risk of Occupational Latent Tuberculosis Infection among Health Personnel Measured by Interferon-Gamma Release Assays in Low Incidence Countries-A Systematic Review and Meta-Analysis.

health personnel interferon-gamma release assays (IGRA) latent tuberculosis infection (LTBI) low incidence countries occupational risk

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
16 01 2020
Historique:
received: 30 12 2019
revised: 10 01 2020
accepted: 12 01 2020
entrez: 23 1 2020
pubmed: 23 1 2020
medline: 8 7 2020
Statut: epublish

Résumé

Healthcare workers (HCWs) have increased risk for latent tuberculosis infection (LTBI) and tuberculosis (TB) disease due to their occupational exposure. For some years now, interferon-γ release assays (IGRAs) have replaced the tuberculin skin test for the diagnosis of LTBI in many countries. This review examined the occupational risk of LTBI in HCWs with IGRA testing in low incidence countries. A systematic review and meta-analysis of studies from 2005 onwards provide data regarding the prevalence of LTBI in HCWs. In addition, the pooled effect estimates were calculated for individual regions and occupational groups. 57 studies with 31,431 HCWs from four regions and a total of 25 countries were analysed. The prevalence of LTBI varied from 0.9 to 85.5%. The pooled estimation found the lowest prevalence of LTBI for North American and West Pacific countries (<5%), and the highest prevalence for Eastern Mediterranean countries (19.4%). An increased risk for LTBI was found only for administrative employees. Studies on the occupational risk of LTBI continue to show increased prevalence of HCWs, even in low-incidence countries. Good quality studies will continue to be needed to describe occupational exposure.

Identifiants

pubmed: 31963207
pii: ijerph17020581
doi: 10.3390/ijerph17020581
pmc: PMC7027002
pii:
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Références

Rev Chilena Infectol. 2014 Jun;31(3):254-60
pubmed: 25146198
Epidemiol Health. 2016 Jul 24;38:e2016032
pubmed: 27457062
Infect Control Hosp Epidemiol. 2006 May;27(5):442-8
pubmed: 16671023
Scand J Infect Dis. 2007;39(6-7):554-9
pubmed: 17577817
Am J Respir Crit Care Med. 2014 Jan 1;189(1):77-87
pubmed: 24299555
BMC Res Notes. 2012 Jan 20;5:52
pubmed: 22264277
Presse Med. 2011 Dec;40(12 Pt 1):e516-20
pubmed: 21549552
Emerg Infect Dis. 2011 Mar;17(3):488-94
pubmed: 21392441
Caspian J Intern Med. 2016 Spring;7(2):82-7
pubmed: 27386058
Infect Control Hosp Epidemiol. 2009 Mar;30(3):215-21
pubmed: 19191484
PLoS One. 2012;7(8):e43014
pubmed: 22916197
Int J Tuberc Lung Dis. 2007 Jun;11(6):593-605
pubmed: 17519089
Expert Rev Anti Infect Ther. 2013 Jan;11(1):37-48
pubmed: 23428101
Can Respir J. 2012 Mar-Apr;19(2):84-8
pubmed: 22536576
Enferm Infecc Microbiol Clin. 2015 Oct;33(8):525-31
pubmed: 25613557
Infection. 2017 Jun;45(3):283-290
pubmed: 27866367
J Occup Med Toxicol. 2009 Nov 30;4:30
pubmed: 19948042
Eur Respir J. 2019 Apr 18;53(4):
pubmed: 30792341
Intern Med. 2014;53(11):1119-24
pubmed: 24881734
J Pak Med Assoc. 2016 Mar;66(3):270-4
pubmed: 26968275
Pol Arch Med Wewn. 2014;124(1-2):36-42
pubmed: 24343239
BMC Public Health. 2013 Apr 17;13:353
pubmed: 23590619
Infect Control Hosp Epidemiol. 2009 Sep;30(9):876-83
pubmed: 19614541
J Occup Med Toxicol. 2013 May 07;8:12
pubmed: 23647777
Jpn J Infect Dis. 2007 May;60(2-3):102-5
pubmed: 17515641
PLoS One. 2016 Oct 6;11(10):e0164034
pubmed: 27711155
Infect Control Hosp Epidemiol. 2009 Jun;30(6):581-4
pubmed: 19415970
Ig Sanita Pubbl. 2016 Mar-Apr;72(2):137-43
pubmed: 27336958
Ann Saudi Med. 2018 Mar-Apr;38(2):90-96
pubmed: 29620541
Cent Eur J Public Health. 2015 Dec;23(4):324-30
pubmed: 26841146
BMC Infect Dis. 2011 Sep 19;11:245
pubmed: 21929799
Med Sci Monit. 2014 Mar 29;20:521-9
pubmed: 24681806
PLoS One. 2007 Aug 29;2(8):e803
pubmed: 17726533
PLoS One. 2014 Dec 26;9(12):e115322
pubmed: 25541947
Open Forum Infect Dis. 2017 Aug 29;4(3):ofx137
pubmed: 28875155
Tohoku J Exp Med. 2013;230(2):87-91
pubmed: 23759899
GMS Hyg Infect Control. 2016 Oct 12;11:Doc22
pubmed: 27777875
Intern Med. 2017;56(7):773-779
pubmed: 28381742
PLoS One. 2016 May 05;11(5):e0154803
pubmed: 27148876
Lung. 2009 Nov-Dec;187(6):413-9
pubmed: 19830489
Ann Clin Lab Sci. 2013 Spring;43(2):221-9
pubmed: 23694799
J Hosp Infect. 2008 May;69(1):69-76
pubmed: 18403047
Int J Occup Med Environ Health. 2011 Dec;24(4):359-66
pubmed: 22086450
G Ital Med Lav Ergon. 2007 Jul-Sep;29(3 Suppl):406-7
pubmed: 18409747
BMC Infect Dis. 2010 Apr 30;10:107
pubmed: 20429957
PLoS One. 2009 Aug 24;4(8):e6686
pubmed: 19701460
Respiration. 2005 Jul-Aug;72(4):431-46
pubmed: 16088290
Med Lav. 2012 Jan-Feb;103(1):26-36
pubmed: 22486073
Epidemiol Infect. 2017 Apr;145(6):1095-1106
pubmed: 28065210
Thorax. 2012 Jan;67(1):62-70
pubmed: 21228420
Int J Mycobacteriol. 2017 Jan-Mar;6(1):83-86
pubmed: 28317810
J Infect Public Health. 2014 Jul-Aug;7(4):289-95
pubmed: 24835036
Ann Intern Med. 2008 Aug 5;149(3):177-84
pubmed: 18593687
Diagn Microbiol Infect Dis. 2013 Mar;75(3):277-81
pubmed: 23276770
Infect Control Hosp Epidemiol. 2015 May;36(5):569-74
pubmed: 25682769
J Occup Med Toxicol. 2011 Jun 09;6:19
pubmed: 21658231
Euro Surveill. 2009 Oct 29;14(43):
pubmed: 19883555
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
N Z Med J. 2012 Feb 10;125(1349):21-9
pubmed: 22327155
Arch Environ Occup Health. 2019;74(3):109-114
pubmed: 30516445
BMJ. 2009 Jul 21;339:b2535
pubmed: 19622551
Arch Med Res. 2009 Feb;40(2):103-8
pubmed: 19237019
Eur Respir J. 2011 Jan;37(1):88-99
pubmed: 21030451
J Occup Med Toxicol. 2009 Jan 09;4:1
pubmed: 19134168
J Occup Med Toxicol. 2014 Jul 08;9:24
pubmed: 25018775
Infect Control Hosp Epidemiol. 2008 Jul;29(7):681-3
pubmed: 18624672
J Infect Public Health. 2014 Nov-Dec;7(6):481-8
pubmed: 25194817
Tuberk Toraks. 2011;59(1):43-7
pubmed: 21554229
J Immunol Methods. 2014 Dec 1;414:51-7
pubmed: 25111618
Springerplus. 2013 Sep 05;2:440
pubmed: 24102039
J Infect Public Health. 2014 Jul-Aug;7(4):356-9
pubmed: 24702746

Auteurs

Claudia Peters (C)

Competence Center for Epidemiology and Health Services Research for Healthcare Professionals (CVcare), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.

Agnessa Kozak (A)

Competence Center for Epidemiology and Health Services Research for Healthcare Professionals (CVcare), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.

Albert Nienhaus (A)

Competence Center for Epidemiology and Health Services Research for Healthcare Professionals (CVcare), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.
Department of Occupational Medicine, Hazardous Substances and Public Health, Institution for Statutory Accident Insurance and Prevention in the Health and Welfare Services (BGW), 22089 Hamburg, Germany.

Anja Schablon (A)

Competence Center for Epidemiology and Health Services Research for Healthcare Professionals (CVcare), Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH